Follow-up Visit with Time A 62-year-old male patient returns to the office for a follow-up visit for chronic idiopathic gout without tophi. The patient’s present uric acid level is 4.0, and he is now taking allopurinol 450 mg per day. Previously, he was taken off indapamide due to an increase in his uric acid. He…
Search results for: allopurinol
Phase 3 Studies Evaluate Lesinurad for Gout Treatment
For 12 months, two studies examined the use of lesinurad in combination with allopurinol to treat gout, with patients achieving reduced serum uric acid levels and demonstrating no severe toxicity.
Biosimilar for Infliximab Launched in Europe
Plus, updates on arhalofenate, ALO-02, and other rheumatology drug news, safety information
Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do
Lack of efficacy, poor DAS scores may be misinterpreted as a drug failure
2014 ACR/ARHP Annual Meeting: New Directions for Gout
Economics of care, more aggressive treatment targets needed for better gout management
Gout, Glucose Metabolism and Obesity: A Case Review
New research explores association between hyperurecimia and gout with metabolic derangement
Treatment, Management Options for Difficult-to-Control Gout
Patient education is key to medication compliance, battling gouty flares
Bariatric Surgery May Help Obese Patients with Gout, Diabetes
Researchers found patients with morbid obesity, gout and diabetes achieved target serum urate concentrations post-bariatric surgery
Coding Corner Question: August
Level 4 coding for a follow-up visit by a patient with gout
Teaching Rheumatology in Haiti
Rheumatologist Ronald J. Anderson, MD, describes volunteer experience with medical residents, teaching rheumatology
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- 12
- Next Page »